0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Human Insulin Regular Market Research Report 2025
Published Date: January 2025
|
Report Code: QYRE-Auto-37Q11641
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Human Insulin Regular Market Research Report 2022
BUY CHAPTERS

Global Human Insulin Regular Market Research Report 2025

Code: QYRE-Auto-37Q11641
Report
January 2025
Pages:90
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Human Insulin Regular Market

The global market for Human Insulin Regular was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Human Insulin Regular is a type of insulin medication that is used to control blood sugar levels in people with diabetes. It is a short-acting insulin that is identical to the insulin produced by the human body. Human Insulin Regular is typically injected subcutaneously before meals to help regulate blood sugar levels after eating. It works by facilitating the uptake of glucose from the bloodstream into the body"s cells, where it can be used for energy or stored for later use. Human Insulin Regular is available by prescription and is commonly used in the treatment of both type 1 and type 2 diabetes.
North American market for Human Insulin Regular is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Human Insulin Regular is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Human Insulin Regular include Gan & Lee Pharmaceuticals, Bioton, Novo Nordisk, Tonghua Dongbao Pharmaceutical, Shenzhen Kexing Pharmaceutical, Zhuhai United Laboratories, Wanbang Biopharmaceuticals, Eli Lilly and Company, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Human Insulin Regular, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Insulin Regular.
The Human Insulin Regular market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Human Insulin Regular market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Insulin Regular manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Human Insulin Regular Market Report

Report Metric Details
Report Name Human Insulin Regular Market
by Type
by Application
  • Hospital
  • Clinic
Production by Region
  • North America
  • Europe
  • China
  • Japan
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Gan & Lee Pharmaceuticals, Bioton, Novo Nordisk, Tonghua Dongbao Pharmaceutical, Shenzhen Kexing Pharmaceutical, Zhuhai United Laboratories, Wanbang Biopharmaceuticals, Eli Lilly and Company
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Human Insulin Regular manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Production/output, value of Human Insulin Regular by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
  • Chapter 4: Consumption of Human Insulin Regular in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 10: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Human Insulin Regular Market report?

Ans: The main players in the Human Insulin Regular Market are Gan & Lee Pharmaceuticals, Bioton, Novo Nordisk, Tonghua Dongbao Pharmaceutical, Shenzhen Kexing Pharmaceutical, Zhuhai United Laboratories, Wanbang Biopharmaceuticals, Eli Lilly and Company

What are the Application segmentation covered in the Human Insulin Regular Market report?

Ans: The Applications covered in the Human Insulin Regular Market report are Hospital, Clinic

What are the Type segmentation covered in the Human Insulin Regular Market report?

Ans: The Types covered in the Human Insulin Regular Market report are Insulin Glargine, Recombinant Insulin Glargine

Recommended Reports

Insulin Devices

Insulin Drug Markets

Insulin Accessories

1 Human Insulin Regular Market Overview
1.1 Product Definition
1.2 Human Insulin Regular by Type
1.2.1 Global Human Insulin Regular Market Value Growth Rate Analysis by Type: 2024 VS 2031
1.2.2 Insulin Glargine
1.2.3 Recombinant Insulin Glargine
1.3 Human Insulin Regular by Application
1.3.1 Global Human Insulin Regular Market Value Growth Rate Analysis by Application: 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Market Growth Prospects
1.4.1 Global Human Insulin Regular Production Value Estimates and Forecasts (2020-2031)
1.4.2 Global Human Insulin Regular Production Capacity Estimates and Forecasts (2020-2031)
1.4.3 Global Human Insulin Regular Production Estimates and Forecasts (2020-2031)
1.4.4 Global Human Insulin Regular Market Average Price Estimates and Forecasts (2020-2031)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Human Insulin Regular Production Market Share by Manufacturers (2020-2025)
2.2 Global Human Insulin Regular Production Value Market Share by Manufacturers (2020-2025)
2.3 Global Key Players of Human Insulin Regular, Industry Ranking, 2023 VS 2024
2.4 Global Human Insulin Regular Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Human Insulin Regular Average Price by Manufacturers (2020-2025)
2.6 Global Key Manufacturers of Human Insulin Regular, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Human Insulin Regular, Product Offered and Application
2.8 Global Key Manufacturers of Human Insulin Regular, Date of Enter into This Industry
2.9 Human Insulin Regular Market Competitive Situation and Trends
2.9.1 Human Insulin Regular Market Concentration Rate
2.9.2 Global 5 and 10 Largest Human Insulin Regular Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Human Insulin Regular Production by Region
3.1 Global Human Insulin Regular Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.2 Global Human Insulin Regular Production Value by Region (2020-2031)
3.2.1 Global Human Insulin Regular Production Value by Region (2020-2025)
3.2.2 Global Forecasted Production Value of Human Insulin Regular by Region (2026-2031)
3.3 Global Human Insulin Regular Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.4 Global Human Insulin Regular Production Volume by Region (2020-2031)
3.4.1 Global Human Insulin Regular Production by Region (2020-2025)
3.4.2 Global Forecasted Production of Human Insulin Regular by Region (2026-2031)
3.5 Global Human Insulin Regular Market Price Analysis by Region (2020-2025)
3.6 Global Human Insulin Regular Production and Value, Year-over-Year Growth
3.6.1 North America Human Insulin Regular Production Value Estimates and Forecasts (2020-2031)
3.6.2 Europe Human Insulin Regular Production Value Estimates and Forecasts (2020-2031)
3.6.3 China Human Insulin Regular Production Value Estimates and Forecasts (2020-2031)
3.6.4 Japan Human Insulin Regular Production Value Estimates and Forecasts (2020-2031)
4 Human Insulin Regular Consumption by Region
4.1 Global Human Insulin Regular Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
4.2 Global Human Insulin Regular Consumption by Region (2020-2031)
4.2.1 Global Human Insulin Regular Consumption by Region (2020-2025)
4.2.2 Global Human Insulin Regular Forecasted Consumption by Region (2026-2031)
4.3 North America
4.3.1 North America Human Insulin Regular Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.3.2 North America Human Insulin Regular Consumption by Country (2020-2031)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Human Insulin Regular Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.4.2 Europe Human Insulin Regular Consumption by Country (2020-2031)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Human Insulin Regular Consumption Growth Rate by Region: 2020 VS 2024 VS 2031
4.5.2 Asia Pacific Human Insulin Regular Consumption by Region (2020-2031)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Human Insulin Regular Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.6.2 Latin America, Middle East & Africa Human Insulin Regular Consumption by Country (2020-2031)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Human Insulin Regular Production by Type (2020-2031)
5.1.1 Global Human Insulin Regular Production by Type (2020-2025)
5.1.2 Global Human Insulin Regular Production by Type (2026-2031)
5.1.3 Global Human Insulin Regular Production Market Share by Type (2020-2031)
5.2 Global Human Insulin Regular Production Value by Type (2020-2031)
5.2.1 Global Human Insulin Regular Production Value by Type (2020-2025)
5.2.2 Global Human Insulin Regular Production Value by Type (2026-2031)
5.2.3 Global Human Insulin Regular Production Value Market Share by Type (2020-2031)
5.3 Global Human Insulin Regular Price by Type (2020-2031)
6 Segment by Application
6.1 Global Human Insulin Regular Production by Application (2020-2031)
6.1.1 Global Human Insulin Regular Production by Application (2020-2025)
6.1.2 Global Human Insulin Regular Production by Application (2026-2031)
6.1.3 Global Human Insulin Regular Production Market Share by Application (2020-2031)
6.2 Global Human Insulin Regular Production Value by Application (2020-2031)
6.2.1 Global Human Insulin Regular Production Value by Application (2020-2025)
6.2.2 Global Human Insulin Regular Production Value by Application (2026-2031)
6.2.3 Global Human Insulin Regular Production Value Market Share by Application (2020-2031)
6.3 Global Human Insulin Regular Price by Application (2020-2031)
7 Key Companies Profiled
7.1 Gan & Lee Pharmaceuticals
7.1.1 Gan & Lee Pharmaceuticals Human Insulin Regular Company Information
7.1.2 Gan & Lee Pharmaceuticals Human Insulin Regular Product Portfolio
7.1.3 Gan & Lee Pharmaceuticals Human Insulin Regular Production, Value, Price and Gross Margin (2020-2025)
7.1.4 Gan & Lee Pharmaceuticals Main Business and Markets Served
7.1.5 Gan & Lee Pharmaceuticals Recent Developments/Updates
7.2 Bioton
7.2.1 Bioton Human Insulin Regular Company Information
7.2.2 Bioton Human Insulin Regular Product Portfolio
7.2.3 Bioton Human Insulin Regular Production, Value, Price and Gross Margin (2020-2025)
7.2.4 Bioton Main Business and Markets Served
7.2.5 Bioton Recent Developments/Updates
7.3 Novo Nordisk
7.3.1 Novo Nordisk Human Insulin Regular Company Information
7.3.2 Novo Nordisk Human Insulin Regular Product Portfolio
7.3.3 Novo Nordisk Human Insulin Regular Production, Value, Price and Gross Margin (2020-2025)
7.3.4 Novo Nordisk Main Business and Markets Served
7.3.5 Novo Nordisk Recent Developments/Updates
7.4 Tonghua Dongbao Pharmaceutical
7.4.1 Tonghua Dongbao Pharmaceutical Human Insulin Regular Company Information
7.4.2 Tonghua Dongbao Pharmaceutical Human Insulin Regular Product Portfolio
7.4.3 Tonghua Dongbao Pharmaceutical Human Insulin Regular Production, Value, Price and Gross Margin (2020-2025)
7.4.4 Tonghua Dongbao Pharmaceutical Main Business and Markets Served
7.4.5 Tonghua Dongbao Pharmaceutical Recent Developments/Updates
7.5 Shenzhen Kexing Pharmaceutical
7.5.1 Shenzhen Kexing Pharmaceutical Human Insulin Regular Company Information
7.5.2 Shenzhen Kexing Pharmaceutical Human Insulin Regular Product Portfolio
7.5.3 Shenzhen Kexing Pharmaceutical Human Insulin Regular Production, Value, Price and Gross Margin (2020-2025)
7.5.4 Shenzhen Kexing Pharmaceutical Main Business and Markets Served
7.5.5 Shenzhen Kexing Pharmaceutical Recent Developments/Updates
7.6 Zhuhai United Laboratories
7.6.1 Zhuhai United Laboratories Human Insulin Regular Company Information
7.6.2 Zhuhai United Laboratories Human Insulin Regular Product Portfolio
7.6.3 Zhuhai United Laboratories Human Insulin Regular Production, Value, Price and Gross Margin (2020-2025)
7.6.4 Zhuhai United Laboratories Main Business and Markets Served
7.6.5 Zhuhai United Laboratories Recent Developments/Updates
7.7 Wanbang Biopharmaceuticals
7.7.1 Wanbang Biopharmaceuticals Human Insulin Regular Company Information
7.7.2 Wanbang Biopharmaceuticals Human Insulin Regular Product Portfolio
7.7.3 Wanbang Biopharmaceuticals Human Insulin Regular Production, Value, Price and Gross Margin (2020-2025)
7.7.4 Wanbang Biopharmaceuticals Main Business and Markets Served
7.7.5 Wanbang Biopharmaceuticals Recent Developments/Updates
7.8 Eli Lilly and Company
7.8.1 Eli Lilly and Company Human Insulin Regular Company Information
7.8.2 Eli Lilly and Company Human Insulin Regular Product Portfolio
7.8.3 Eli Lilly and Company Human Insulin Regular Production, Value, Price and Gross Margin (2020-2025)
7.8.4 Eli Lilly and Company Main Business and Markets Served
7.8.5 Eli Lilly and Company Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Human Insulin Regular Industry Chain Analysis
8.2 Human Insulin Regular Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Human Insulin Regular Production Mode & Process Analysis
8.4 Human Insulin Regular Sales and Marketing
8.4.1 Human Insulin Regular Sales Channels
8.4.2 Human Insulin Regular Distributors
8.5 Human Insulin Regular Customer Analysis
9 Human Insulin Regular Market Dynamics
9.1 Human Insulin Regular Industry Trends
9.2 Human Insulin Regular Market Drivers
9.3 Human Insulin Regular Market Challenges
9.4 Human Insulin Regular Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
List of Tables
 Table 1. Global Human Insulin Regular Market Value by Type, (US$ Million) & (2024 VS 2031)
 Table 2. Global Human Insulin Regular Market Value by Application, (US$ Million) & (2024 VS 2031)
 Table 3. Global Human Insulin Regular Production Capacity (Tons) by Manufacturers in 2024
 Table 4. Global Human Insulin Regular Production by Manufacturers (2020-2025) & (Tons)
 Table 5. Global Human Insulin Regular Production Market Share by Manufacturers (2020-2025)
 Table 6. Global Human Insulin Regular Production Value by Manufacturers (2020-2025) & (US$ Million)
 Table 7. Global Human Insulin Regular Production Value Share by Manufacturers (2020-2025)
 Table 8. Global Key Players of Human Insulin Regular, Industry Ranking, 2023 VS 2024
 Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value in Human Insulin Regular as of 2024)
 Table 10. Global Market Human Insulin Regular Average Price by Manufacturers (US$/Ton) & (2020-2025)
 Table 11. Global Key Manufacturers of Human Insulin Regular, Manufacturing Base Distribution and Headquarters
 Table 12. Global Key Manufacturers of Human Insulin Regular, Product Offered and Application
 Table 13. Global Key Manufacturers of Human Insulin Regular, Date of Enter into This Industry
 Table 14. Global Human Insulin Regular Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 15. Mergers & Acquisitions, Expansion Plans
 Table 16. Global Human Insulin Regular Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 17. Global Human Insulin Regular Production Value (US$ Million) by Region (2020-2025)
 Table 18. Global Human Insulin Regular Production Value Market Share by Region (2020-2025)
 Table 19. Global Human Insulin Regular Production Value (US$ Million) Forecast by Region (2026-2031)
 Table 20. Global Human Insulin Regular Production Value Market Share Forecast by Region (2026-2031)
 Table 21. Global Human Insulin Regular Production Comparison by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 22. Global Human Insulin Regular Production (Tons) by Region (2020-2025)
 Table 23. Global Human Insulin Regular Production Market Share by Region (2020-2025)
 Table 24. Global Human Insulin Regular Production (Tons) Forecast by Region (2026-2031)
 Table 25. Global Human Insulin Regular Production Market Share Forecast by Region (2026-2031)
 Table 26. Global Human Insulin Regular Market Average Price (US$/Ton) by Region (2020-2025)
 Table 27. Global Human Insulin Regular Market Average Price (US$/Ton) by Region (2026-2031)
 Table 28. Global Human Insulin Regular Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 29. Global Human Insulin Regular Consumption by Region (2020-2025) & (Tons)
 Table 30. Global Human Insulin Regular Consumption Market Share by Region (2020-2025)
 Table 31. Global Human Insulin Regular Forecasted Consumption by Region (2026-2031) & (Tons)
 Table 32. Global Human Insulin Regular Forecasted Consumption Market Share by Region (2026-2031)
 Table 33. North America Human Insulin Regular Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)
 Table 34. North America Human Insulin Regular Consumption by Country (2020-2025) & (Tons)
 Table 35. North America Human Insulin Regular Consumption by Country (2026-2031) & (Tons)
 Table 36. Europe Human Insulin Regular Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)
 Table 37. Europe Human Insulin Regular Consumption by Country (2020-2025) & (Tons)
 Table 38. Europe Human Insulin Regular Consumption by Country (2026-2031) & (Tons)
 Table 39. Asia Pacific Human Insulin Regular Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 40. Asia Pacific Human Insulin Regular Consumption by Region (2020-2025) & (Tons)
 Table 41. Asia Pacific Human Insulin Regular Consumption by Region (2026-2031) & (Tons)
 Table 42. Latin America, Middle East & Africa Human Insulin Regular Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)
 Table 43. Latin America, Middle East & Africa Human Insulin Regular Consumption by Country (2020-2025) & (Tons)
 Table 44. Latin America, Middle East & Africa Human Insulin Regular Consumption by Country (2026-2031) & (Tons)
 Table 45. Global Human Insulin Regular Production (Tons) by Type (2020-2025)
 Table 46. Global Human Insulin Regular Production (Tons) by Type (2026-2031)
 Table 47. Global Human Insulin Regular Production Market Share by Type (2020-2025)
 Table 48. Global Human Insulin Regular Production Market Share by Type (2026-2031)
 Table 49. Global Human Insulin Regular Production Value (US$ Million) by Type (2020-2025)
 Table 50. Global Human Insulin Regular Production Value (US$ Million) by Type (2026-2031)
 Table 51. Global Human Insulin Regular Production Value Market Share by Type (2020-2025)
 Table 52. Global Human Insulin Regular Production Value Market Share by Type (2026-2031)
 Table 53. Global Human Insulin Regular Price (US$/Ton) by Type (2020-2025)
 Table 54. Global Human Insulin Regular Price (US$/Ton) by Type (2026-2031)
 Table 55. Global Human Insulin Regular Production (Tons) by Application (2020-2025)
 Table 56. Global Human Insulin Regular Production (Tons) by Application (2026-2031)
 Table 57. Global Human Insulin Regular Production Market Share by Application (2020-2025)
 Table 58. Global Human Insulin Regular Production Market Share by Application (2026-2031)
 Table 59. Global Human Insulin Regular Production Value (US$ Million) by Application (2020-2025)
 Table 60. Global Human Insulin Regular Production Value (US$ Million) by Application (2026-2031)
 Table 61. Global Human Insulin Regular Production Value Market Share by Application (2020-2025)
 Table 62. Global Human Insulin Regular Production Value Market Share by Application (2026-2031)
 Table 63. Global Human Insulin Regular Price (US$/Ton) by Application (2020-2025)
 Table 64. Global Human Insulin Regular Price (US$/Ton) by Application (2026-2031)
 Table 65. Gan & Lee Pharmaceuticals Human Insulin Regular Company Information
 Table 66. Gan & Lee Pharmaceuticals Human Insulin Regular Specification and Application
 Table 67. Gan & Lee Pharmaceuticals Human Insulin Regular Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 68. Gan & Lee Pharmaceuticals Main Business and Markets Served
 Table 69. Gan & Lee Pharmaceuticals Recent Developments/Updates
 Table 70. Bioton Human Insulin Regular Company Information
 Table 71. Bioton Human Insulin Regular Specification and Application
 Table 72. Bioton Human Insulin Regular Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 73. Bioton Main Business and Markets Served
 Table 74. Bioton Recent Developments/Updates
 Table 75. Novo Nordisk Human Insulin Regular Company Information
 Table 76. Novo Nordisk Human Insulin Regular Specification and Application
 Table 77. Novo Nordisk Human Insulin Regular Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 78. Novo Nordisk Main Business and Markets Served
 Table 79. Novo Nordisk Recent Developments/Updates
 Table 80. Tonghua Dongbao Pharmaceutical Human Insulin Regular Company Information
 Table 81. Tonghua Dongbao Pharmaceutical Human Insulin Regular Specification and Application
 Table 82. Tonghua Dongbao Pharmaceutical Human Insulin Regular Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 83. Tonghua Dongbao Pharmaceutical Main Business and Markets Served
 Table 84. Tonghua Dongbao Pharmaceutical Recent Developments/Updates
 Table 85. Shenzhen Kexing Pharmaceutical Human Insulin Regular Company Information
 Table 86. Shenzhen Kexing Pharmaceutical Human Insulin Regular Specification and Application
 Table 87. Shenzhen Kexing Pharmaceutical Human Insulin Regular Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 88. Shenzhen Kexing Pharmaceutical Main Business and Markets Served
 Table 89. Shenzhen Kexing Pharmaceutical Recent Developments/Updates
 Table 90. Zhuhai United Laboratories Human Insulin Regular Company Information
 Table 91. Zhuhai United Laboratories Human Insulin Regular Specification and Application
 Table 92. Zhuhai United Laboratories Human Insulin Regular Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 93. Zhuhai United Laboratories Main Business and Markets Served
 Table 94. Zhuhai United Laboratories Recent Developments/Updates
 Table 95. Wanbang Biopharmaceuticals Human Insulin Regular Company Information
 Table 96. Wanbang Biopharmaceuticals Human Insulin Regular Specification and Application
 Table 97. Wanbang Biopharmaceuticals Human Insulin Regular Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 98. Wanbang Biopharmaceuticals Main Business and Markets Served
 Table 99. Wanbang Biopharmaceuticals Recent Developments/Updates
 Table 100. Eli Lilly and Company Human Insulin Regular Company Information
 Table 101. Eli Lilly and Company Human Insulin Regular Specification and Application
 Table 102. Eli Lilly and Company Human Insulin Regular Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 103. Eli Lilly and Company Main Business and Markets Served
 Table 104. Eli Lilly and Company Recent Developments/Updates
 Table 105. Key Raw Materials Lists
 Table 106. Raw Materials Key Suppliers Lists
 Table 107. Human Insulin Regular Distributors List
 Table 108. Human Insulin Regular Customers List
 Table 109. Human Insulin Regular Market Trends
 Table 110. Human Insulin Regular Market Drivers
 Table 111. Human Insulin Regular Market Challenges
 Table 112. Human Insulin Regular Market Restraints
 Table 113. Research Programs/Design for This Report
 Table 114. Key Data Information from Secondary Sources
 Table 115. Key Data Information from Primary Sources
 Table 116. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Human Insulin Regular
 Figure 2. Global Human Insulin Regular Market Value by Type, (US$ Million) & (2020-2031)
 Figure 3. Global Human Insulin Regular Market Share by Type: 2024 VS 2031
 Figure 4. Insulin Glargine Product Picture
 Figure 5. Recombinant Insulin Glargine Product Picture
 Figure 6. Global Human Insulin Regular Market Value by Application, (US$ Million) & (2020-2031)
 Figure 7. Global Human Insulin Regular Market Share by Application: 2024 VS 2031
 Figure 8. Hospital
 Figure 9. Clinic
 Figure 10. Global Human Insulin Regular Production Value (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Human Insulin Regular Production Value (US$ Million) & (2020-2031)
 Figure 12. Global Human Insulin Regular Production Capacity (Tons) & (2020-2031)
 Figure 13. Global Human Insulin Regular Production (Tons) & (2020-2031)
 Figure 14. Global Human Insulin Regular Average Price (US$/Ton) & (2020-2031)
 Figure 15. Human Insulin Regular Report Years Considered
 Figure 16. Human Insulin Regular Production Share by Manufacturers in 2024
 Figure 17. Global Human Insulin Regular Production Value Share by Manufacturers (2024)
 Figure 18. Human Insulin Regular Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. The Global 5 and 10 Largest Players: Market Share by Human Insulin Regular Revenue in 2024
 Figure 20. Global Human Insulin Regular Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 21. Global Human Insulin Regular Production Value Market Share by Region: 2020 VS 2024 VS 2031
 Figure 22. Global Human Insulin Regular Production Comparison by Region: 2020 VS 2024 VS 2031 (Tons)
 Figure 23. Global Human Insulin Regular Production Market Share by Region: 2020 VS 2024 VS 2031
 Figure 24. North America Human Insulin Regular Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 25. Europe Human Insulin Regular Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 26. China Human Insulin Regular Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 27. Japan Human Insulin Regular Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 28. Global Human Insulin Regular Consumption by Region: 2020 VS 2024 VS 2031 (Tons)
 Figure 29. Global Human Insulin Regular Consumption Market Share by Region: 2020 VS 2024 VS 2031
 Figure 30. North America Human Insulin Regular Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 31. North America Human Insulin Regular Consumption Market Share by Country (2020-2031)
 Figure 32. U.S. Human Insulin Regular Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 33. Canada Human Insulin Regular Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 34. Europe Human Insulin Regular Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 35. Europe Human Insulin Regular Consumption Market Share by Country (2020-2031)
 Figure 36. Germany Human Insulin Regular Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 37. France Human Insulin Regular Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 38. U.K. Human Insulin Regular Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 39. Italy Human Insulin Regular Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 40. Russia Human Insulin Regular Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 41. Asia Pacific Human Insulin Regular Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 42. Asia Pacific Human Insulin Regular Consumption Market Share by Region (2020-2031)
 Figure 43. China Human Insulin Regular Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 44. Japan Human Insulin Regular Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 45. South Korea Human Insulin Regular Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 46. China Taiwan Human Insulin Regular Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 47. Southeast Asia Human Insulin Regular Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 48. India Human Insulin Regular Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 49. Latin America, Middle East & Africa Human Insulin Regular Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 50. Latin America, Middle East & Africa Human Insulin Regular Consumption Market Share by Country (2020-2031)
 Figure 51. Mexico Human Insulin Regular Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 52. Brazil Human Insulin Regular Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 53. Turkey Human Insulin Regular Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 54. GCC Countries Human Insulin Regular Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 55. Global Production Market Share of Human Insulin Regular by Type (2020-2031)
 Figure 56. Global Production Value Market Share of Human Insulin Regular by Type (2020-2031)
 Figure 57. Global Human Insulin Regular Price (US$/Ton) by Type (2020-2031)
 Figure 58. Global Production Market Share of Human Insulin Regular by Application (2020-2031)
 Figure 59. Global Production Value Market Share of Human Insulin Regular by Application (2020-2031)
 Figure 60. Global Human Insulin Regular Price (US$/Ton) by Application (2020-2031)
 Figure 61. Human Insulin Regular Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture